Communications scientifiques 2019

Articles

• Cowppli-Bony A, Trétarre B, Marrer E, Defossez G, Daubisse-Marliac L, Coureau G, Minicozzi P, Woronoff AS, Delafosse P, Molinié F; FRANCIM network. Compliance with clinical guidelines for breast cancer management: A population-based study of quality-of-care indicators in France. PLoS One. 2019;14:e0224275.
• Matysiak-Budnik T, Jamet P, Ruskoné-Fourmestraux A, de Mascarel A, Velten M, Maynadié M, Woronoff AS, Trétarre B, Marrer E, Delafosse P, Ligier K, Lapôtre Ledoux B, Daubisse L, Bouzid L, Orazio S, Cowppli-Bony A, Monnereau A. Gastric MALT lymphoma in a population-based study in France: clinical features, treatments and survival. Aliment Pharmacol Ther. 2019. [Epub ahead of print]
• Lamy S, Molinié F, Daubisse-Marliac L, Cowppli-Bony A, Ayrault-Piault S, Fournier E, Woronoff AS, Delpierre C, Grosclaude P. Using ecological socioeconomic position (SEP) measures to deal with sample bias introduced by incomplete individual-level measures: inequalities in breast cancer stage at diagnosis as an example. BMC Public Health. 2019;19:857.
• Cowppli-Bony A, Colonna M, Ligier K, Jooste V, Defossez G, Monnereau A; le Réseau Francim; Réseau des registres de cancer Francim. [Descriptive epidemiology of cancer in metropolitan France: Incidence, survival and prevalence]. Bull Cancer. 2019;106:617-634.
• Woronoff AS, Molinié F, Trétarre B. [Implementation of National Cervical Cancer Screening Program in France]. Bull Cancer. 2019;106:253-261.
• Minicozzi P, Van Eycken L, Molinie F, Innos K, Guevara M, Marcos-Gragera R, Castro C, Rapiti E, Katalinic A, Torrella A, Žagar T, Bielska-Lasota M, Giorgi Rossi P, Larrañaga N, Bastos J, Sánchez MJ, Sant M; European HR Working Group on breast cancer. Comorbidities, age and period of diagnosis influence treatment and outcomes in early breast cancer. Int J Cancer. 2019;144:2118-2127.

Working groups :

FRANCIM

• Jooste V, Bouvier AM, Bossard N, Uhry Z, Coureau G, Remontet L, Dantony E; French Network of Cancer Registries (FRANCIM). Trends in probabilities of death owing to cancer and owing to other causes in patients with colon cancer. Eur J Gastroenterol Hepatol. 2019;31:570-576.
• Le Stang N, Bouvier V, Glehen O, Villeneuve L; FRANCIM network; MESOPATH Referent National Center, Galateau-Sallé F, Clin B. Incidence and survival of peritoneal malignant mesothelioma between 1989 and 2015: A population-based study. Cancer Epidemiol. 2019;60:106-111.
• Romain G, Boussari O, Bossard N, Remontet L, Bouvier AM, Mounier M, Iwaz J, Colonna M, Jooste V; French Network of Cancer Registries (FRANCIM). Time-to-cure and cure proportion in solid cancers in France. A population based study. Cancer Epidemiol. 2019;60:93-101.
• Tron L, Belot A, Fauvernier M, Remontet L, Bossard N, Launay L, Bryere J, Monnereau A, Dejardin O, Launoy G; French Network of Cancer Registries (FRANCIM). Socioeconomic environment and disparities in cancer survival for 19 solid tumor sites: An analysis of the French Network of Cancer Registries (FRANCIM) data. Int J Cancer. 2019;144:1262-1274.

ETIOSARC

• Lacourt A, Amadéo B, Gramond C, Marrer E, Plouvier S, Baldi I, Blay JY, Coindre JM, de Pinieux G, Gouin F, Italiano A, Le Cesne A, Le Loarer F, Monnereau A, Pellegrin I, Penel N, Ray-Coquard I, Toulmonde M, Ducimetière F, Mathoulin-Pélissier S; Etiosarc study group. ETIOSARC study : environmental aetiology of sarcomas from a French prospective multicentric population-based case-control study-study protocol. BMJ Open. 2019;9:e030013.

AGRICAN

• Piel C, Pouchieu C, Carles C, Béziat B, Boulanger M, Bureau M, Busson A, Grüber A, Lecluse Y, Migault L, Renier M, Rondeau V, Schwall X, Tual S; AGRICAN group, Pierre L, Baldi I. Agricultural exposures to carbamate herbicides and fungicides and central nervous system tumour incidence in the cohort AGRICAN. Environ Int. 2019;130:104876.

ICARE

• Radoï L, Sylla F, Matrat M, Barul C, Menvielle G, Delafosse P, Stücker I, Luce D; ICARE study group. Head and neck cancer and occupational exposure to leather dust: results from the ICARE study, a French case-control study. Environ Health. 2019;18:27.

RARECARE

• Imbimbo M, Maury JM, Garassino M, Girard N; RARECAREnet Working Group. Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting. Eur J Surg Oncol. 2019;45:75-80.
• Nicolai N, Biasoni D, Catanzaro MA, Colecchia M, Trama A; RARECAREnet Working Group. Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference. Eur J Surg Oncol. 2019;45:60-66
• Orlandi E, Alfieri S, Simon C, Trama A, Licitra L; RARECAREnet Working Group. Treatment challenges in and outside a network setting: Head and neck cancers. Eur J Surg Oncol. 2019;45:40-45.
• Gatta G, Trama A, Capocaccia R; RARECARENet Working Group. Epidemiology of rare cancers and inequalities in oncologic outcomes. Eur J Surg Oncol. 2019;45:3-11.
• Lykoudis PM, Partelli S, Muffatti F, Caplin M, Falconi M, Fusai GK; RARECARENet Working Group. Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours. Eur J Surg Oncol. 2019;45:46-51.
• Pasquali S, Bonvalot S, Tzanis D, Casali PG, Trama A, Gronchi A; RARECARENet Working Group. Treatment challenges in and outside a network setting: Soft tissue sarcomas. Eur J Surg Oncol. 2019;45:31-39.
• Ray-Coquard I, Trama A, Seckl MJ, Fotopoulou C, Pautier P, Pignata S, Kristensen G, Mangili G, Falconer H, Massuger L, Sehouli J, Pujade-Lauraine E, Lorusso D, Amant F, Rokkones E, Vergote I, Ledermann JA; RARECARENet Working Group. Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting. Eur J Surg Oncol. 2019;45:67-74.
• Trama A, Bernasconi A, McCabe MG, Guevara M, Gatta G, Botta L; RARECAREnet Working Group, Ries L, Bleyer A. Is the cancer survival improvement in European and American adolescent and young adults still lagging behind that in children? Pediatr Blood Cancer. 2019;66:e27407.